Basic and clinical science posters: Beta cells, islets and stem cells

Basic and clinical science posters: Beta cells, islets and stem cells P15 Identification of pro‐apoptotic signalling through the GPRC5B receptor in beta cells by CRISPR‐Cas9‐mediated genome editingP ATANES, I Ruz‐Maldonado, R Hawkes, B Liu, S Amisten, SJ PersaudDepartment of Diabetes, Faculty of Life Sciences & Medicine, King's College London, London, UKBackground/AimsGPRC5B is an orphan receptor that is highly expressed in human and mouse islets, and we have previously reported that its down‐regulation in islets protects against apoptosis. As there are no agonists identified for GPRC5B, we investigated its role in MIN6 beta cells by stably deleting it using the CRISPR‐Cas9 technology, then re‐introducing it in a graded fashion.Methods: Efficiency of GFP plasmid delivery into MIN6 beta cells was determined by cell sorting following transfection with eight reagents. CRISPR‐Cas9 was used to stably delete the Gprc5b gene in MIN6 beta cells, and 0.01% to 100% Gprc5b plasmid was introduced by transient transfection to restore Gprc5b expression. Standard techniques were used to quantify Gprc5b mRNA expression, apoptosis, and signalling pathways downstream of GPRC5B were identified using Cignal 45‐Pathway Reporter Arrays and western blotting.Results: JetPRIME® provided the best MIN6 beta cell transfection efficiency (29 ± 0.5% GFP‐positive cells). Isolation of Gprc5b KO cell clones using CRISPR‐Cas9 was established, and DNA sequencing confirmed deletion of Gprc5b http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Diabetic Medicine Wiley

Basic and clinical science posters: Beta cells, islets and stem cells

Loading next page...
 
/lp/wiley/basic-and-clinical-science-posters-beta-cells-islets-and-stem-cells-UilsKFAYnE
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
Diabetic Medicine © 2018 Diabetes UK
ISSN
0742-3071
eISSN
1464-5491
D.O.I.
10.1111/dme.3_13571
Publisher site
See Article on Publisher Site

Abstract

P15 Identification of pro‐apoptotic signalling through the GPRC5B receptor in beta cells by CRISPR‐Cas9‐mediated genome editingP ATANES, I Ruz‐Maldonado, R Hawkes, B Liu, S Amisten, SJ PersaudDepartment of Diabetes, Faculty of Life Sciences & Medicine, King's College London, London, UKBackground/AimsGPRC5B is an orphan receptor that is highly expressed in human and mouse islets, and we have previously reported that its down‐regulation in islets protects against apoptosis. As there are no agonists identified for GPRC5B, we investigated its role in MIN6 beta cells by stably deleting it using the CRISPR‐Cas9 technology, then re‐introducing it in a graded fashion.Methods: Efficiency of GFP plasmid delivery into MIN6 beta cells was determined by cell sorting following transfection with eight reagents. CRISPR‐Cas9 was used to stably delete the Gprc5b gene in MIN6 beta cells, and 0.01% to 100% Gprc5b plasmid was introduced by transient transfection to restore Gprc5b expression. Standard techniques were used to quantify Gprc5b mRNA expression, apoptosis, and signalling pathways downstream of GPRC5B were identified using Cignal 45‐Pathway Reporter Arrays and western blotting.Results: JetPRIME® provided the best MIN6 beta cell transfection efficiency (29 ± 0.5% GFP‐positive cells). Isolation of Gprc5b KO cell clones using CRISPR‐Cas9 was established, and DNA sequencing confirmed deletion of Gprc5b

Journal

Diabetic MedicineWiley

Published: Jan 1, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial